Malaria ‘viral’ vaccine shows promising early results

By  |  0 Comments

Malaria ‘viral’ vaccine shows promising early results

A test of a malaria vaccine that targets the most risky variety of parasite that causes the disease has shown some positive early results.

The vaccine that developed at Oxford University was 67% successful in a study of 121 men in Kenya, it found.

Encouraging the results have now been recorded for two malaria vaccines, after 20 years of research.

Current tests of a different vaccine in more advanced trials showed signs of it working in young children.

With regarding 1,300 children dying in sub-Saharan Africa from malaria every day, scientists desire a vaccine to protect those most at risk.

According to World Health Organization, there were 198 million cases of malaria in 2013 and about 584,000 deaths related to the disease.

But it has taken scientists more than two decades to make any real progress, due to the nature of the parasites transmitted to people through the bites of infected mosquitoes.

In total, there are 4 different parasites that cause malaria. It is not yet known whether Oxford vaccine protects against all variants of Plasmodium falciparum parasite or just one. Read More………..


Recommended For You

Read More  Breastfeeding Twin Babies

Learning By Day and Writer By Night

Leave a Reply

Your email address will not be published. Required fields are marked *